RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      대장암 환자의 한약 및 침치료에 대한 국내외 임상연구 결과에 대한 고찰 = Pubmed를 중심으로

      한글로보기

      https://www.riss.kr/link?id=A102021610

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The aim of this study was to collect and analyze the clinical studies of traditional herbal medicine and acupuncture treatments for colorectal cancer patients searched in Pubmed and Cochrane library in English. We collected the clinical studies, including randomized controlled trial, case control study and cohort study, in the PubMed and Cochrane library using keywords ‘Colorectal Cancer’, ‘Korean Medicine’, ‘Traditional Chinese Medicine’, ‘Kampo’ and ‘Acupuncture’. Then we analyzed them according to the objective of the therapy, i.e. improving therapy prognosis, reducing chemotherapy’s adverse event and reducing operational adverse event. In case RCT, we evaluate the quality of the study with jadad scale. Total 18 studies were selected. There were 3 studies about improving therapy prognosis, 6 studies about reducing chemotherapy’s adverse event and 9 studies about reducing operational adverse event. Traditional medicine might improve therapy prognosis in terms of the survival rate, relapse/metastasis rate, quality of life and immune function. The specific herbal formula, ‘Goshajinkigan’ might not be successful about reducing chemotherapy’s adverse event, peripheral neurotoxicity. ‘Hangeshanshinto’ might reduce the duration of oral mucositis but it is not clear to reduce the incidence of that. ‘PHY906’ might reduce the incidence of diarrhea. Acupuncture might reduce operational adverse event such as gastrointestinal dysfunction and pain. And ‘Daikenchuto’ might not be successful in reducing operational adverse event, gastrointestinal dysfunction. Further studies are needed to clarify the efficacy of traditional herbal medicine and acupuncture for colorectal cancer patients.
      번역하기

      The aim of this study was to collect and analyze the clinical studies of traditional herbal medicine and acupuncture treatments for colorectal cancer patients searched in Pubmed and Cochrane library in English. We collected the clinical studies, inclu...

      The aim of this study was to collect and analyze the clinical studies of traditional herbal medicine and acupuncture treatments for colorectal cancer patients searched in Pubmed and Cochrane library in English. We collected the clinical studies, including randomized controlled trial, case control study and cohort study, in the PubMed and Cochrane library using keywords ‘Colorectal Cancer’, ‘Korean Medicine’, ‘Traditional Chinese Medicine’, ‘Kampo’ and ‘Acupuncture’. Then we analyzed them according to the objective of the therapy, i.e. improving therapy prognosis, reducing chemotherapy’s adverse event and reducing operational adverse event. In case RCT, we evaluate the quality of the study with jadad scale. Total 18 studies were selected. There were 3 studies about improving therapy prognosis, 6 studies about reducing chemotherapy’s adverse event and 9 studies about reducing operational adverse event. Traditional medicine might improve therapy prognosis in terms of the survival rate, relapse/metastasis rate, quality of life and immune function. The specific herbal formula, ‘Goshajinkigan’ might not be successful about reducing chemotherapy’s adverse event, peripheral neurotoxicity. ‘Hangeshanshinto’ might reduce the duration of oral mucositis but it is not clear to reduce the incidence of that. ‘PHY906’ might reduce the incidence of diarrhea. Acupuncture might reduce operational adverse event such as gastrointestinal dysfunction and pain. And ‘Daikenchuto’ might not be successful in reducing operational adverse event, gastrointestinal dysfunction. Further studies are needed to clarify the efficacy of traditional herbal medicine and acupuncture for colorectal cancer patients.

      더보기

      참고문헌 (Reference)

      1 정진형, "위암의 중의약 치료에 대한 문헌적 고찰" 대한한방내과학회 35 (35): 332-342, 2014

      2 김명화, "암환자의 보완대체요법 이용 양상" 한국농촌의학.지역보건학회 32 (32): 155-167, 2007

      3 선승호, "암환자의 방사선 요법 및 화학요법 치료 후 발생된 백혈구감소증의 치료에 관한 중의학 임상논문의 문헌적 고찰" 대한한방내과학회 23 (23): 171-122, 2002

      4 Shibata, C., "The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs" 126 (126): 918-924, 1999

      5 Lam, W., "The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity" 2 (2): 45-59, 2010

      6 Zhong, L. L., "The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis" 20 (20): 240-252, 2012

      7 Yoshikawa, K., "The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection" 42 (42): 646-651, 2012

      8 Suehiro, T., "The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery" 52 (52): 97-100, 2005

      9 Nishioka, M., "The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen" 16 (16): 322-327, 2011

      10 Kase, Y., "Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat" 75 (75): 407-413, 1997

      1 정진형, "위암의 중의약 치료에 대한 문헌적 고찰" 대한한방내과학회 35 (35): 332-342, 2014

      2 김명화, "암환자의 보완대체요법 이용 양상" 한국농촌의학.지역보건학회 32 (32): 155-167, 2007

      3 선승호, "암환자의 방사선 요법 및 화학요법 치료 후 발생된 백혈구감소증의 치료에 관한 중의학 임상논문의 문헌적 고찰" 대한한방내과학회 23 (23): 171-122, 2002

      4 Shibata, C., "The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs" 126 (126): 918-924, 1999

      5 Lam, W., "The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity" 2 (2): 45-59, 2010

      6 Zhong, L. L., "The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: a systematic review and meta-analysis" 20 (20): 240-252, 2012

      7 Yoshikawa, K., "The effects of the Kampo medicine (Japanese herbal medicine) "Daikenchuto" on the surgical inflammatory response following laparoscopic colorectal resection" 42 (42): 646-651, 2012

      8 Suehiro, T., "The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery" 52 (52): 97-100, 2005

      9 Nishioka, M., "The Kampo medicine, Goshajinkigan, prevents neuropathy in patients treated by FOLFOX regimen" 16 (16): 322-327, 2011

      10 Kase, Y., "Preventive effects of Hange-shashin-to on irinotecan hydrochloride-caused diarrhea and its relevance to the colonic prostaglandin E2 and water absorption in the rat" 75 (75): 407-413, 1997

      11 Hosokawa, A., "Preventive effect of traditional Japanese medicine on neurotoxicity of FOLFOX for metastatic colorectal cancer: a multicenter retrospective study" 32 (32): 2545-2550, 2012

      12 Mori, K., "Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer" 51 (51): 403-406, 2003

      13 Oki, E., "Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study" 20 (20): 767-775, 2015

      14 Rockwell, S., "Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy" 89 (89): 16-25, 2013

      15 Lam, W., "PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment" 5 : 9384-, 2015

      16 Liu, S. H., "Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy" 140 (140): 614-623, 2012

      17 Kono, T., "Multitargeted effects of hangeshashinto for treatment of chemotherapy-induced oral mucositis on inducible prostaglandin E2 production in human oral keratinocytes" 13 (13): 435-445, 2014

      18 Kim, S. M., "Literature review on qigong exercise in cancer patients focusing on Randomized Controlled Clinical Trials" 38 (38): 51-56, 2013

      19 Kim, S. M., "Literature review on aroma inhalation therapy using aromatic essential oils in cancer patients" 38 (38): 57-62, 2013

      20 Okumi, H., "Kampo medicine for palliative care in Japan" 8 (8): 6-, 2014

      21 Gotoh, A., "Inhibition mechanism of Gosha-jinki-gan on the micturition reflex in rats" 96 (96): 115-123, 2004

      22 Mizuno, K., "Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat" 125 (125): 91-98, 2014

      23 Ng, S. S., "Electroacupuncture for ileus after laparoscopic colorectal surgery: a randomised sham-controlled study" 19 (19): 33-35, 2013

      24 Zhang, Z., "Electroacupuncture at ST36 accelerates the recovery of gastrointestinal motility after colorectal surgery: a randomised controlled trial" 32 (32): 223-226, 2014

      25 Meng, Z. Q., "Electro-acupuncture to prevent prolonged postoperative ileus: a randomized clinical trial" 16 (16): 104-111, 2010

      26 Kono, T., "Efficacy of goshajinkigan for peripheral neurotoxicity of oxaliplatin in patients with advanced or recurrent colorectal cancer" 2011 : 418481-, 2011

      27 Yasunaga, H., "Effect of the Japanese herbal kampo medicine dai-kenchu-to on postoperative adhesive small bowel obstruction requiring long-tube decompression: a propensity score analysis" 2011 : 264289-, 2011

      28 Hu, X., "Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats" 59 (59): 103-111, 2003

      29 Nagano, T., "Effect of Dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma" 22 (22): 1131-1133, 1999

      30 Matsuda, C., "Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine -based colorectal cancer chemotherapy-induced oral mucositis" 76 (76): 97-103, 2015

      31 Yaegashi, M., "Daikenchuto stimulates colonic motility after laparoscopic-assisted colectomy" 61 (61): 85-89, 2014

      32 Kono, T., "Complementary and synergistic therapeutic effects of compounds found in Kampo medicine: analysis of daikenchuto" 6 : 159-, 2015

      33 McCulloch, M., "Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods" 10 (10): 240-259, 2011

      34 Yang, Y. F., "Cohort study on the effect of a combined treatment of traditional Chinese medicine and Western medicine on the relapse and metastasis of 222 patients with stage II and III colorectal cancer after radical operation" 14 (14): 251-256, 2008

      35 Zhou, L. Y., "Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine" 15 (15): 107-111, 2009

      36 Katsuno, H., "Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902)" 45 (45): 650-656, 2015

      37 Salaga, M., "Chinese herbal medicines in the treatment of IBD and colorectal cancer: a review" 15 (15): 405-420, 2014

      38 "Cancer Statistics" National Cancer Information Center

      39 "Cancer Incidence Trends" National Cancer Information Center

      40 Yamada, K., "Aconiti tuber increases plasma nitrite and nitrate levels in humans" 96 (96): 165-169, 2005

      41 Deng, G., "A phase II, randomized, controlled trial of acupuncture for reduction of Postcolectomy Ileus" 20 (20): 1164-1169, 2013

      42 Kummar, S., "A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer" 10 (10): 85-96, 2011

      43 Kim, J. B., "A Comparative Study between East and West Medicine on the Colorectal Cancer" 9 (9): 89-127, 1995

      더보기

      동일학술지(권/호) 다른 논문

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2026 평가예정 재인증평가 신청대상 (재인증)
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-03-10 학술지명변경 외국어명 : Korean Journal of Oriental Physiology & Pathology -> Journal of Physiology & Pathology in Korean Medicine KCI등재
      2016-02-24 학회명변경 한글명 : 대한동의병리학회 -> 한의병리학회
      영문명 : The Korean Society Of Oriental Pathology -> The Society of Pathology in Korean Medicine
      KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-09-03 학술지명변경 외국어명 : Korean Journal of Oriental Medical Pathology -> Korean Journal of Oriental Physiology & Pathology KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.47 0.47 0.41
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.35 0.33 0.485 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼